Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial
General Info
Time period covered
January, 2004 - December, 2006
Data type
Scientific literature
Keywords
Citation
Journal
J Hypertens
Pages
403–11
Publication year
2008
Suggested citation
Schmieder RE, Kjeldsen SE, Julius S, McInnes GT, Zanchetti A, Hua TA, VALUE Trial Group. Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial. J Hypertens. 2008; 26(3): 403–11.